Toll Free : + 1-888-961-4454 | Int'l : + 91 (788) 802-9103 | support@researchdive.com
LI23108849 |
Pages: 310 |
Sep 2023 |
Bone Grafts and Substitutes Overview
The industry involved in the creation, production, and distribution of products and materials used in bone grafting techniques is referred to as the "bone grafts and substitutes market." Bone grafting is a surgical operation used to replace or repair bone tissue that has been lost or injured as a result of an illness, an accident, or other circumstances. In this technique, bone grafts or replacements are used to reinforce the afflicted area structurally and encourage the creation of new bone. With traditional bone grafts, the patient's bone is transplanted (autografts) or bone from a donor is used (allografts). However, developments in medical technology have produced artificial bone graft substitutes that can take the place of conventional transplants.
In orthopedic surgery, dental procedures, and other sectors where bone regeneration is required, the bone grafts and substitutes market is crucial. It includes a broad spectrum of tools and products utilized in numerous clinical settings, including biologics, scaffolds, growth factors, and bone grafting materials. The rise in the prevalence of bone-related illnesses, the increased need for minimally invasive surgical techniques, and technological developments in biomaterials are some of the reasons driving the market. Medical device firms, pharmaceutical businesses, and research organizations that work on the creation and marketing of cutting-edge products are important players in the bone grafts and substitutes industry. To improve the patient's quality of life and hasten the healing process, the bone grafts and substitutes market is concentrated on offering efficient solutions for bone regeneration and repair.
Global Bone Grafts and Substitutes Market Analysis
The global bone grafts and substitutes market size was $2,722.4 million in 2022 and is predicted to grow at a CAGR of 5.1%, by generating a revenue of $4,407.7 million by 2032.
COVID-19 Impact on Global Bone Grafts and Substitutes Market
The world economy as a whole, particularly the healthcare sector, has been significantly impacted by the COVID-19 epidemic. The pandemic also had an impact on the bone grafts and substitutes market, which is essential to orthopedic and dentistry surgeries. The pandemic caused a disturbance in the world's supply chain as many nations instituted travel bans and lockdowns to stop the virus's spread. As a result, there were difficulties with the production and distribution of bone grafts and alternatives, which caused shortages in some areas. Orthopedic operations and other non-essential procedures were delayed or cancelled as a result of hospitals and healthcare facilities concentrating their resources and attention on treating COVID-19 patients. Patients were also reluctant to have elective procedures because of fear of infections or because there weren't enough resources for medical care. This hesitation had a further negative impact on the bone grafts and substitutes industry.
On the plus side, the rising popularity of telemedicine and virtual consultations has given medical professionals the chance to remotely counsel and support patients. Thishelps in preserving a certain level of patient involvement and lets medical personnel determine whether bone grafts and replacements are necessary for each situation. . Thus, in the post-pandemic period, when things are gradually returning to normal, the market is anticipated to recover, propelled by the increase in demand for orthopedic and dental services as well as the commencement of elective procedures.
Growing Adoption of Telemedecine to Drive the Market Growth
The bone grafts and substitutes market is poised for significant growth due to the growing adoption of telemedicine through remote collaboration in the healthcare industry. Telemedicine through remote collaboration has become increasingly important in recent times, driven by factors such as the COVID-19 pandemic and advancements in technology. One area where remote collaboration is proving to be particularly beneficial is in the field of bone grafts and substitutes. These products are widely used in orthopedic surgeries to promote bone healing and regeneration. To get around these obstacles, healthcare providers can work remotely and take advantage of tools like telemedicine, virtual consultations, and digital imaging. Surgeons can consult with patients online, examine their medical records and imaging scans, and choose the best bone graft or replacement for their unique requirements. This lessens the need for in-person appointments and enables more effective and customized treatment approaches. The creation of bone grafts and substitutes now has additional options because of developments in 3D printing and tissue engineering. Researchers, engineers, and surgeons can work together remotely to develop and create specialized grafts and replacements that are tailored to the anatomy and needs of the patient. This degree of accuracy and personalization can greatly enhance surgical results and patient satisfaction. The healthcare sector's expanding need for remote collaboration, particularly in the area of bone grafts and substitutes, is anticipated to fuel market expansion. In terms of patient care, surgical outcomes, and overall efficiency, the ability to remotely consult, plan, and devise personalized treatment approaches using cutting-edge technologies offers substantial advantages. The market for bone grafts and substitutes is projected to have good growth in the upcoming years as remote cooperation gains momentum.
Concerns Related to Infections to Restrain the Market Growth
The market for bone grafts and substitutes has expanded significantly in recent years, propelled by reasons such as an ageing population, an increase in the prevalence of orthopedic illnesses, and technological developments in medicine. However, certain challenges can limit industry expansion. The possibility of infection is one of the mainhurdles in the full-fledged growth of the market for bone grafts and substitutes. The possibility of infection is increased by surgical treatments using bone grafts and substitutes that may introduce foreign substances into the body. Infections can result in a slow healing process and in extreme circumstances can cause implant failure. The market's growth may be constrained if patients and medical professionals decide not to use bone transplants and alternatives due to these hazards. The possibility of implant rejection or negative reactions is yet another challenge. There is always a chance that the body will reject bone grafts and substitutes, which are frequently made of biological or synthetic components. Immune and allergic reactions can result in implant failure and the requirement for additional procedures. Patients and healthcare professionals may become anxious as a result of such hazards, which could harm the market's potential for expansion. Another important issue in the market for bone grafts and substitutes is data security. There is a higher danger of data breaches and unauthorized access to patient information as digital platforms and electronic medical records are used more frequently. Sensitive personal and financial information may be found in private medical records about bone graft procedures, making them appealing targets. Although the market for bone grafts and substitutes has a lot of growth potential, issues like infection risks, implant rejection, data security, and expensive costs could limit its development. It will be crucial to address these issues to guarantee the market's continued growth and maximize its advantages for patients all over the world. This can be done by implementing improved safety procedures, stringent testing, enhanced cybersecurity measures, and cost-effective solutions.
Advancements in Technology to Drive Excellent Opportunities
The market for bone grafts and substitutes now offers many attractive options, thanks in large part to technological advancements. The expansion and improvement of bone grafting procedures have been facilitated by notable advancements in regenerative medicine, biomaterials, and tissue engineering over time. One significant development is the creation of artificial bone graft replacements. These alternatives are made to imitate the characteristics of real bone, offering structural support and encouraging bone regrowth. They can be designed to match the demands of a particular patient and are built from biocompatible materials like composites, polymers, or ceramics. In comparison to conventional grafting techniques, synthetic bone graft substitutes provide several benefits, including a lower risk of disease transmission, increased availability, and simpler handling. The rise of 3D printing in bone grafting is another important technological development. Complex and patient-specific bone grafts and scaffolds can be made via 3D printing. With the help of this technique, the shape, porosity, and mechanical characteristics of the grafts may be precisely controlled, improving their integration with the surrounding tissue and accelerating recovery. Demineralized bone matrix (DBM) and growth factors are two examples of biologic grafts that provide a bioactive and natural method of bone repair. These grafts contain chemicals that activate the body's healing mechanisms and encourage the growth of new bone tissue. The effectiveness and clinical results of biological grafts have been substantially improved by the development of more sophisticated processing methods and better delivery systems. Technology developments have offered new possibilities for bone grafts and alternatives. These developments have increased patient treatment options while also enhancing the safety and effectiveness of bone grafting treatments.
Global Bone Grafts and Substitutes Market Share, by Type, 2022
The bone grafts substitute sub-segment accounted for the highest market share in 2022. A wide variety of goods used in orthopedic and dental procedures to encourage bone healing and regeneration are included in the bone grafts substitutes sub-segment. Bone graft substitutes are made to imitate the characteristics of real bone and act as a scaffold for the development of new bone. They are frequently utilized in a variety of orthopedic treatments, including dental implant procedures, joint repair, trauma surgery, and spinal fusion. Bone graft replacements come in a variety of forms, including artificial materials, ceramics, biologics, and tissue-engineered goods. Materials like calcium phosphate, hydroxyapatite, or tricalcium phosphate are frequently used to make synthetic bone graft alternatives because they offer structural support and promote bone formation. Bone graft substitutes have proteins and growth factors that are present in nature that promote bone regrowth and development. On the other hand, tissue-engineered products use cells, scaffolds, and growth factors to build a customized graft that encourages the creation of new bone. In the bone grafts and substitutes market, the bone graft substitutes segment is essential because it offers healthcare providers with a variety of solutions to help patients who need orthopedic or dental operations for promoting bone repair and regeneration.
Global Bone Grafts and Substitutes Market Share, by Application, 2022
The spinal fusion sub-segment accounted for the highest market share in 2022. The market for bone substitutes and grafts is significantly impacted by the spinal fusion segment. A surgical operation called spinal fusion, which tries to stabilize and fuse two or more vertebrae, is frequently used to treat several spinal problems like spinal stenosis, degenerative disc disease, and spinal fractures. In this treatment, bone grafts or replacements are used to encourage bone development and speed up the fusion process. When utilized in spinal fusion surgeries, bone grafts and substitutes offer structural support and encourage the growth of new bone, which helps the vertebral segments fuse. They do, however, necessitate an additional surgical site for harvesting, which can result in issues with the donor site and worsen patient suffering. Technological advancements and research in the field have led to the development of innovative products and techniques for spinal fusion procedures. These include bone morphogenetic proteins (BMPs) that stimulate bone growth and minimally invasive surgical approaches that reduce patient trauma and promote faster recovery. The growing frequency of spinal problems, the ageing population, and the rising desire for minimally invasive surgical treatments are driving the growth of the spinal fusion segment in the bone substitutes and grafts market. The market for bone grafts and substitutes is constantly changing as healthcare providers work to improve patient outcomes and lower healthcare costs. Ongoing research and development efforts are concentrated on increasing the efficacy, safety, and accessibility of grafting materials for spinal fusion procedures.
Global Bone Grafts and Substitutes Market Share, by End-User, 2022
The hospitals sub-segment accounted for the highest market share in 2022. Hospitals frequently use bone grafts and substitutes for a variety of operations, such as joint replacements, spinal fusion surgeries, and fracture treatment. To expedite bone healing, encourage bone growth, and provide structural support, these treatments frequently call for the use of bone grafts and replacements. Hospitals frequently offer specialized orthopedic departments and well-equipped operating rooms, making them the perfect location for conducting bone graft surgeries. In addition, hospitals typically employ a broad spectrum of medical specialists, such as orthopedic surgeons, anesthesiologists, and skilled nursing personnel, who are educated to conduct bone graft procedures and provide post-operative care. Hospitals are essential to the study and development of bone grafts and substitutes in addition to surgical treatments. To perform clinical studies, assess the effectiveness of novel grafting materials, and improve the science of bone regeneration, numerous hospitals work in partnership with academic institutions, medical device manufacturers, and research organizations. Overall, the hospital sector continues to be a significant user of bone grafts and alternatives, boosting demand for cutting-edge grafting goods, surgical methods, and regenerative therapies.
Global Bone Grafts and Substitutes Market Share, by Region, 2022
The North America bone grafts and substitutes market generated the highest revenue in 2022. North America has become a significant market for bone grafts and substitutes due to its sophisticated healthcare infrastructure, large healthcare spending, and a strong emphasis on research and development. With an ageing population and an increase in bone illnesses such as osteoporosis, osteoarthritis, and spinal injuries, the demand for bone grafts and substitutes in the region has increased. To encourage bone repair and regeneration, these items are utilized in a range of surgical procedures, such as spinal fusion, joint reconstruction, and trauma surgeries. The market for bone grafts and replacements has expanded in North America as a result of technological developments in the fields of regenerative medicine and tissue engineering. Government programs that support healthcare innovation as well as favorable reimbursement policies have further fueled industry expansion. The development and use of bone grafts and substitutes in North America have also been aided by the existence of significant market participants, such as medical device businesses, biotechnology corporations, and research organizations. It is worth noting that the market in North America faces challenges such as stringent regulatory requirements, high product costs, and the need for extensive clinical evidence to support the efficacy and safety of new products. Nonetheless, the region continues to witness ongoing research and development efforts, collaborations between industry players and academic institutions, and investments in advanced manufacturing technologies to address these challenges and drive market growth in the bone grafts and substitutes sector.
Competitive Scenario in the Global Bone Grafts and Substitutes Market
Investment and agreement are common strategies followed by major market players. Altapore Shape Bioactive Bone Graft, the newest product in the company's range of next-generation bone graft substitutes, was approved by the U.S. Food and Drug Administration (FDA) in July 2020. The Matriform Si, a silicate synthetic bone graft strip created and approved for spinal fusion procedures, will go on sale in the United States in August 2020, according to an announcement made by Xtant Medical Holdings, Inc., a global medical technology firm focused on surgical solutions for the treatment of spinal problems. A leading provider of medical technology, Zimmer Biomet Holdings, Inc., said in January 2023 that it has achieved a binding deal to buy Embody, Inc., a privately held manufacturer of soft tissue healing devices. The nation's largest member-driven provider of healthcare performance improvement, Vizient, Inc., awarded a contract for innovative technology to Integra LifeSciences Holding Corporation's SurgiMend collagen matrix for soft tissue reconstruction in July 2021.
Some of the leading bone grafts and substitutes market players are Xtant Medical Holdings, Inc., Baxter International Inc., Integra LifeSciences, Arthrex Inc., Johnson & Johnson, Medtronic plc, Zimmer Biomet Holdings, Inc., Orthofix Holdings, Inc., Stryker Corporation, NuVasive, Inc.
| Aspect | Particulars |
| Historical Market Estimations | 2020-2022 |
| Base Year for Market Estimation | 2022 |
| Forecast Timeline for Market Projection | 2023-2032 |
| Geographical Scope | North America, Europe, Asia-Pacific, and LAMEA |
| Segmentation by Types |
|
| Segmentation by Applications |
|
|
Segmentation by End User
|
|
| Key Companies Profiled |
|
1. Research Methodology
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
2. Report Scope
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on global bone grafts and substitutes market
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive Rivalry Intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on bone grafts and substitutes market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
5. Bone Grafts And Substitutes Market Analysis, By Types
5.1. Overview
5.2. Allografts
5.2.1. Definition, key trends, growth factors, and opportunities
5.2.2. Market size analysis, by region, 2022-2032
5.2.3. Market share analysis, by country, 2022-2032
5.3. Bone Grafts Substitute
5.3.1. Definition, key trends, growth factors, and opportunities
5.3.2. Market size analysis, by region, 2022-2032
5.3.3. Market share analysis, by country, 2022-2032
5.4. Cell-based Matrices
5.4.1. Definition, key trends, growth factors, and opportunities
5.4.2. Market size analysis, by region, 2022-2032
5.4.3. Market share analysis, by country, 2022-2032
5.5. Research Dive Exclusive Insights
5.5.1. Market attractiveness
5.5.2. Competition heatmap
6. Bone Grafts And Substitutes Market Analysis, by Applications
6.1. Overview
6.2. Spinal Fusion
6.2.1. Definition, key trends, growth factors, and opportunities
6.2.2. Market size analysis, by region, 2022-2032
6.2.3. Market share analysis, by country, 2022-2032
6.3. Trauma
6.3.1. Definition, key trends, growth factors, and opportunities
6.3.2. Market size analysis, by region, 2022-2032
6.3.3. Market share analysis, by country, 2022-2032
6.4. Joint Reconstruction
6.4.1. Definition, key trends, growth factors, and opportunities
6.4.2. Market size analysis, by region, 2022-2032
6.4.3. Market share analysis, by country, 2022-2032
6.5. Dental Bone Grafting
6.5.1. Definition, key trends, growth factors, and opportunities
6.5.2. Market size analysis, by region, 2022-2032
6.5.3. Market share analysis, by country, 2022-2032
6.6. Craniomaxillofacial
6.6.1. Definition, key trends, growth factors, and opportunities
6.6.2. Market size analysis, by region, 2022-2032
6.6.3. Market share analysis, by country, 2022-2032
6.7. Research Dive Exclusive Insights
6.7.1. Market attractiveness
6.7.2. Competition heatmap
7. Bone Grafts And Substitutes Market Analysis, by End User
7.1. Overview
7.2. Hospitals
7.2.1. Definition, key trends, growth factors, and opportunities
7.2.2. Market size analysis, by region, 2022-2032
7.2.3. Market share analysis, by country, 2022-2032
7.3. Specialty Clinics
7.3.1. Definition, key trends, growth factors, and opportunities
7.3.2. Market size analysis, by region, 2022-2032
7.3.3. Market share analysis, by country, 2022-2032
7.4. Others
7.4.1. Definition, key trends, growth factors, and opportunities
7.4.2. Market size analysis, by region, 2022-2032
7.4.3. Market share analysis, by country, 2022-2032
7.5. Research Dive Exclusive Insights
7.5.1. Market attractiveness
7.5.2. Competition heatmap
8. Bone Grafts And Substitutes Market, by Region
8.1. North America
8.1.1. U.S.
8.1.1.1. Market size analysis, by Types, 2022-2032
8.1.1.2. Market size analysis, by Applications, 2022-2032
8.1.1.3. Market size analysis, by End User, 2022-2032
8.1.2. Canada
8.1.2.1. Market size analysis, by Types, 2022-2032
8.1.2.2. Market size analysis, by Applications, 2022-2032
8.1.2.3. Market size analysis, by End User, 2022-2032
8.1.3. Mexico
8.1.3.1. Market size analysis, by Types, 2022-2032
8.1.3.2. Market size analysis, by Applications, 2022-2032
8.1.3.3. Market size analysis, by End User, 2022-2032
8.1.4. Research Dive Exclusive Insights
8.1.4.1. Market attractiveness
8.1.4.2. Competition heatmap
8.2. Europe
8.2.1. Germany
8.2.1.1. Market size analysis, by Types, 2022-2032
8.2.1.2. Market size analysis, by Applications, 2022-2032
8.2.1.3. Market size analysis, by End User, 2022-2032
8.2.2. UK
8.2.2.1. Market size analysis, by Types, 2022-2032
8.2.2.2. Market size analysis, by Applications, 2022-2032
8.2.2.3. Market size analysis, by End User, 2022-2032
8.2.3. France
8.2.3.1. Market size analysis, by Types, 2022-2032
8.2.3.2. Market size analysis, by Applications, 2022-2032
8.2.3.3. Market size analysis, by End User, 2022-2032
8.2.4. Spain
8.2.4.1. Market size analysis, by Types, 2022-2032
8.2.4.2. Market size analysis, by Applications, 2022-2032
8.2.4.3. Market size analysis, by End User, 2022-2032
8.2.5. Italy
8.2.5.1. Market size analysis, by Types, 2022-2032
8.2.5.2. Market size analysis, by Applications, 2022-2032
8.2.5.3. Market size analysis, by End User, 2022-2032
8.2.6. Rest of Europe
8.2.6.1. Market size analysis, by Types, 2022-2032
8.2.6.2. Market size analysis, by Applications, 2022-2032
8.2.6.3. Market size analysis, by End User, 2022-2032
8.2.7. Research Dive Exclusive Insights
8.2.7.1. Market attractiveness
8.2.7.2. Competition heatmap
8.3. Asia-Pacific
8.3.1. China
8.3.1.1. Market size analysis, by Types, 2022-2032
8.3.1.2. Market size analysis, by Applications, 2022-2032
8.3.1.3. Market size analysis, by End User, 2022-2032
8.3.2. Japan
8.3.2.1. Market size analysis, by Types, 2022-2032
8.3.2.2. Market size analysis, by Applications, 2022-2032
8.3.2.3. Market size analysis, by End User, 2022-2032
8.3.3. India
8.3.3.1. Market size analysis, by Types, 2022-2032
8.3.3.2. Market size analysis, by Applications, 2022-2032
8.3.3.3. Market size analysis, by End User, 2022-2032
8.3.4. Australia
8.3.4.1. Market size analysis, by Types, 2022-2032
8.3.4.2. Market size analysis, by Applications, 2022-2032
8.3.4.3. Market size analysis, by End User, 2022-2032
8.3.5. Indonesia
8.3.5.1. Market size analysis, by Types, 2022-2032
8.3.5.2. Market size analysis, by Applications, 2022-2032
8.3.5.3. Market size analysis, by End User, 2022-2032
8.3.6. Rest of Asia-Pacific
8.3.6.1. Market size analysis, by Types, 2022-2032
8.3.6.2. Market size analysis, by Applications, 2022-2032
8.3.6.3. Market size analysis, by End User, 2022-2032
8.3.7. Research Dive Exclusive Insights
8.3.7.1. Market attractiveness
8.3.7.2. Competition heatmap
8.4. LAMEA
8.4.1. Brazil
8.4.1.1. Market size analysis, by Types, 2022-2032
8.4.1.2. Market size analysis, by Applications, 2022-2032
8.4.1.3. Market size analysis, by End User, 2022-2032
8.4.2. UAE
8.4.2.1. Market size analysis, by Types, 2022-2032
8.4.2.2. Market size analysis, by Applications, 2022-2032
8.4.2.3. Market size analysis, by End User, 2022-2032
8.4.3. South Africa
8.4.3.1. Market size analysis, by Types, 2022-2032
8.4.3.2. Market size analysis, by Applications, 2022-2032
8.4.3.3. Market size analysis, by End User, 2022-2032
8.4.4. Argentina
8.4.4.1. Market size analysis, by Types, 2022-2032
8.4.4.2. Market size analysis, by Applications, 2022-2032
8.4.4.3. Market size analysis, by End User, 2022-2032
8.4.5. Rest of LAMEA
8.4.5.1. Market size analysis, by Types, 2022-2032
8.4.5.2. Market size analysis, by Applications, 2022-2032
8.4.5.3. Market size analysis, by End User, 2022-2032
8.4.6. Research Dive Exclusive Insights
8.4.6.1. Market attractiveness
8.4.6.2. Competition heatmap
9. Competitive Landscape
9.1. Top winning strategies, 2022
9.1.1. By strategy
9.1.2. By year
9.2. Strategic overview
9.3. Market share analysis, 2022
10. Company Profiles
10.1. Xtant Medical Holdings, Inc.
10.1.1. Overview
10.1.2. Business segments
10.1.3. Product portfolio
10.1.4. Financial performance
10.1.5. Recent developments
10.1.6. SWOT analysis
10.2. Baxter International Inc.
10.2.1. Overview
10.2.2. Business segments
10.2.3. Product portfolio
10.2.4. Financial performance
10.2.5. Recent developments
10.2.6. SWOT analysis
10.3. Integra LifeSciences
10.3.1. Overview
10.3.2. Business segments
10.3.3. Product portfolio
10.3.4. Financial performance
10.3.5. Recent developments
10.3.6. SWOT analysis
10.4. Arthrex, Inc.
10.4.1. Overview
10.4.2. Business segments
10.4.3. Product portfolio
10.4.4. Financial performance
10.4.5. Recent developments
10.4.6. SWOT analysis
10.5. Johnson & Johnson
10.5.1. Overview
10.5.2. Business segments
10.5.3. Product portfolio
10.5.4. Financial performance
10.5.5. Recent developments
10.5.6. SWOT analysis
10.6. Medtronic plc
10.6.1. Overview
10.6.2. Business segments
10.6.3. Product portfolio
10.6.4. Financial performance
10.6.5. Recent developments
10.6.6. SWOT analysis
10.7. Zimmer Biomet Holdings, Inc.
10.7.1. Overview
10.7.2. Business segments
10.7.3. Product portfolio
10.7.4. Financial performance
10.7.5. Recent developments
10.7.6. SWOT analysis
10.8. Orthofix Holdings, Inc.
10.8.1. Overview
10.8.2. Business segments
10.8.3. Product portfolio
10.8.4. Financial performance
10.8.5. Recent developments
10.8.6. SWOT analysis
10.9. Stryker Corporation
10.9.1. Overview
10.9.2. Business segments
10.9.3. Product portfolio
10.9.4. Financial performance
10.9.5. Recent developments
10.9.6. SWOT analysis
10.10. NuVasive, Inc.
10.10.1. Overview
10.10.2. Business segments
10.10.3. Product portfolio
10.10.4. Financial performance
10.10.5. Recent developments
10.10.6. SWOT analysis
* Taxes/Fees, If applicable will be added during checkout. All prices in USD.
Have a question ?
Enquire To BuyNeed to add more ?
Request Customization